Government and Industries Participating in ICBPS-2
China:
The State Food and Drug Administration (SFDA)
The National Institute for the Control of Pharmaceutical and Biological Products
The CDC, Ministry of Health
The Chinese Pharmaceutical Association (CPA)
SINOVAC Biotech Co., Ltd.
Shenzhen THYX Biopharmaceutical Co., Ltd.
The China National Biotec Group (CNBG), a major sponsor, will lead all of its affiliated companies and Insitutes to ICBPS II. These include as a minimum:
China National Scientific Instruments and Materials Import/Export Corporation, Beijing
National Vaccine & Serum Insitute, Beijing
Changchun Institute of Biological Products
ChengDu Institute of Biological Products
Lanzhou Institute of Biological Products.
Shanghai Institute of Biological Products
Wuhan Institute of Biological Products
Beijing Tiantan Biological Products Co., Ltd.
Chengdu Rongsheng Pharmaceuticals Co., Ltd.
International Organizations (to date):
Governmental and International Organizations:
World Health Organization (WHO), Geneva, Switzerland
Department of Health and Human Services (DHHS), BARDA, USA
Department of Defence, Indonesia
Spiros Foundation
International Laboratories and Pharm/BioPharm Organizations:
Battelle Memorial Institute
GlaxoSmithKline (GSK)
Novartis International
Pacific Northwest Laboratories
Sanofi Pasteur
Wyeth Pharmaceuticals
International Institutes and Universities
G. Eliava Institute, Republic of Georgia
Hacettepe University, Turkey
Hawler Medical University, Iraq
Novosibirsk State University, Russia
SRC Virology & Biotechnology VECTOR, Russia
University of Kuopio, Finland
Ain Shams University, Egypt
International Consulting Organizations and Companies
Active Technology Transfer Europe, The Netherlands